Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Beijing Yuanxin Technology

Request full access

With online and offline channels, Yuanxin integrates hospital and out-of-hospital resources and delivers integrated medical insurance solutions

ChinaFounded 2015

About Beijing Yuanxin Technology

Founded in 2015 by He Tao and Daoliang Han, Beijing Yuanxin Technology Group operates as a significant player in China's healthcare technology sector. He Tao, an industry veteran with extensive experience in internet healthcare, previously led the creation of Jianyi Online Pharmacy for China Resources Group before establishing Yuanxin. The company has successfully attracted substantial investment from prominent firms including Tencent, Sequoia Capital China, Qiming Venture Partners, and OrbiMed. Yuanxin has also pursued a public listing on the Hong Kong Stock Exchange, filing prospectuses in October 2021 and April 2022, though the listing has been postponed.

Yuanxin Technology's business model is centered on the patient's entire medical journey, integrating online and offline services to bridge gaps between medical care, pharmaceutical distribution, and health insurance. The firm's operations are structured around three core pillars: out-of-hospital comprehensive patient services, supply-side empowerment, and innovative healthcare services. The majority of its revenue is generated from out-of-hospital patient services, which accounted for 94.6% of total revenue in 2021. This primary segment includes a network of brick-and-mortar pharmacies and the 'Miaoshou Doctor' platform, which was one of the first licensed internet hospitals in China. As of late 2021, the company operated 264 'Yuanxin Pharmacy' branded locations across 30 provinces, complemented by the Miaoshou Doctor online platform, which had an average of 40.2 million monthly users.

The company's key service offerings create a closed-loop system of 'medical-pharmaceutical-insurance'. Through 'Miaoshou Doctor', patients can access services like follow-up consultations and prescription management. The supply-side empowerment services provide hospitals with digital tools and management solutions to improve operational efficiency. The innovative healthcare services division develops solutions for pharmaceutical companies and insurers, including the 'Yuanxin Huibao' insurance technology platform, which assists insurance companies with integrated medical services and data analytics. This platform was established in 2019 to focus on developing novel payment solutions and inclusive insurance products, aiming to make innovative drugs more accessible and affordable for patients.

Source: Dealroom company data

At a glance

Status
Operational
Employees
11
Open positions
None listed
Dealroom signal
24.5/100

Funding history

4 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES FOther financing Aug 2021 $210M $2.3B Sequoia · OrbiMed · Index Capital · UOB Venture ↗
SERIES EOther financing Feb 2021 $465M $1.9B CICC · Sequoia · Tencent · CITIC Securities ↗
Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

Beijing Yuanxin Technology website traffic

Latest recorded traffic for Beijing Yuanxin Technology is 23K monthly website visits, up 32757.1% over the last three months. Beijing Yuanxin Technology's team declined 15.4% over the past year.

Latest monthly visits23K 3-month web change+32757.1% 1-year team growth-15.4%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Beijing Yuanxin Technology in its local ecosystem

Live from Dealroom

The Beijing Yuanxin Technology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

11 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later11 investors entered at this stage

Employees 11 total headcount
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇨🇳 China66.7%
🇭🇰 Hong Kong33.3%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Beijing Yuanxin Technology on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Beijing Yuanxin Technology’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.